What Kinnate Biopharma Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Tananbaum James B. | Director | Apr 03 | Disposition to Issuer · D | −520,711 | — | — | 0 |
| Tananbaum James B. | Director | Apr 03 | Disposition to Issuer · D | −3,525,957 | — | — | 0 |
| Tananbaum James B. | Director | Apr 03 | Disposition to Issuer · D | −9,671,643 | — | — | 0 |
| Foresite Capital Management IV, Llc | 10% owner | Apr 03 | Disposition to Issuer · D | −520,711 | — | — | 0 |
| Foresite Capital Management IV, Llc | 10% owner | Apr 03 | Disposition to Issuer · D | −3,525,957 | — | — | 0 |
| Foresite Capital Management IV, Llc | 10% owner | Apr 03 | Disposition to Issuer · D | −9,671,643 | — | — | 0 |
| Gordon Carl L | Director | Apr 03 | Disposition to Issuer · D | −450,000 | — | — | 0 |
| Gordon Carl L | Director | Apr 03 | Disposition to Issuer · D | −84,599 | — | — | 0 |
| Gordon Carl L | Director | Apr 03 | Disposition to Issuer · D | −1,368,338 | — | — | 0 |
| Gordon Carl L | Director | Apr 03 | Disposition to Issuer · D | −4,738,453 | — | — | 0 |
| Gordon Carl L | Director | Apr 03 | Disposition to Issuer · D | −1,368,339 | — | — | 0 |
| Farzan Nima | CHIEF EXECUTIVE OFFICER | Apr 03 | Disposition to Issuer · D | −2,186 | — | — | 0 |
| Krishnamohan Neha | CHIEF FINANCIAL OFFICER | Apr 03 | Disposition to Issuer · D | −64,087 | — | — | 0 |
| Orbimed Advisors Llc | Director | Apr 03 | Disposition to Issuer · D | −450,000 | — | — | 0 |
| Orbimed Advisors Llc | Director | Apr 03 | Disposition to Issuer · D | −84,599 | — | — | 0 |
| Orbimed Advisors Llc | Director | Apr 03 | Disposition to Issuer · D | −1,368,338 | — | — | 0 |
| Orbimed Advisors Llc | Director | Apr 03 | Disposition to Issuer · D | −4,738,453 | — | — | 0 |
| Orbimed Advisors Llc | Director | Apr 03 | Disposition to Issuer · D | −1,368,339 | — | — | 0 |
| Meltz Mark A | COO GENERAL COUNSEL SECRETARY | Apr 03 | Disposition to Issuer · D | −27,578 | — | — | 0 |
| Flaherty Keith T. | Director | Apr 03 | Disposition to Issuer · D | −66,377 | — | — | 0 |
Loading...
